Treatments:Cancer
From Proteopedia
(Difference between revisions)
Line 5: | Line 5: | ||
* [[Arzerra]] - Generic: Ofatumumab | * [[Arzerra]] - Generic: Ofatumumab | ||
* Rituxan - Generic: Rituximab | * Rituxan - Generic: Rituximab | ||
- | * Zevalin - Generic: Ibritumomab | ||
=====[[Epidermal Growth Factor Receptor]] Inhibitor===== | =====[[Epidermal Growth Factor Receptor]] Inhibitor===== | ||
* [[Herceptin]] - Generic: Trastuzumab | * [[Herceptin]] - Generic: Trastuzumab |
Revision as of 09:49, 14 December 2010
Anti-CD20 Monoclonal Antibody
Epidermal Growth Factor Receptor Inhibitor
Estrogen Receptor Modulator
Multiple Receptor Tyrosine Kinase (VEGFR, PDGFR, EGFR, KIT, Abl) Inhibitor
Vascular Endothelial Growth Factor Inhibitor
|
Proteopedia Page Contributors and Editors (what is this?)
David Canner, Michal Harel, Alexander Berchansky, Karsten Theis